{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:19:54Z","timestamp":1792905594922,"version":"4.5.0"},"reference-count":38,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"unspecified","delay-in-days":103,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Fuji Yakuhin Co., Ltd"},{"name":"Mochida Pharmaceutical Co., Ltd"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2021,7,24]]},"DOI":"10.1080\/14656566.2021.1918102","type":"journal-article","created":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T22:16:22Z","timestamp":1619907382000},"page":"1397-1406","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":47,"title":["Dotinurad: a novel selective urate reabsorption inhibitor for the treatment of hyperuricemia and gout"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3489-2695","authenticated-orcid":false,"given":"Tomohiko","family":"Ishikawa","sequence":"first","affiliation":[{"name":"Medical Affairs Department, Fuji Yakuhin Co., Ltd., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2925-9732","authenticated-orcid":false,"given":"Toshinari","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Mochida Pharmaceutical Co., Ltd., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2244-2999","authenticated-orcid":false,"given":"Tetsuya","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Research Laboratories 2, Fuji Yakuhin Co., Ltd., Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Hosoya","sequence":"additional","affiliation":[{"name":"School of Medicine, Jikei University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"cit0001","unstructured":"Ministry of Health, Labour and Welfare. Comprehensive survey of living conditions. 2016."},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1784556"},{"issue":"4","key":"cit0003","first-page":"319","volume":"55","author":"Hakoda M.","year":"2012","journal-title":"Japan Med Assoc J"},{"key":"cit0004","first-page":"67","volume":"18","author":"Tomita M","year":"2010","journal-title":"Hyperuricemia and Gout"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90441-4"},{"issue":"6","key":"cit0006","first-page":"1501","volume":"27","author":"Lin KC","year":"2000","journal-title":"J Rheumatol"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020040523"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00083.2013"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(04)00934-5"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008010080"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-20-0406"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1506-8"},{"key":"cit0013","author":"Waheed YA","year":"2020","journal-title":"Korean J Intern Med"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1756"},{"key":"cit0015","unstructured":"Hisatome I, Ichida K, Mineo I, et al. Japanese society of gout and uric & nucleic acids 2019 guidelines for management of hyperuricemia and gout 3rd edition. Gout and Uric & Nucleic Acids; 2020:44(Supplement):1\u201340."},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2020.1755251"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2015.1051617"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710895"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32234-0"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(94)80011-1"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.7.967"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.259341"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1177\/0004563218781672"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-019-01836-0"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-019-01825-3"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-019-01816-4"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-019-01818-2"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-020-01849-0"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-020-01851-6"},{"issue":"1","key":"cit0030","first-page":"80","volume":"24","author":"Hosoya T","journal-title":"Clin Exp Nephrol"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2020.03.002"},{"key":"cit0032","unstructured":"Pharmaceutical safety and environmental health bureau, ministry of health, labour and welfare, Japan. Notification No. 0723-4, 2018, Guideline on drug interaction for drug development and appropriate provision of information. pp. 21\u201323. [cited 2021 Jan 18]. Available from: https:\/\/www.pmda.go.jp\/files\/000228122.pdf [issued 2019 Feb 8]"},{"issue":"1","key":"cit0033","first-page":"36","volume":"24","author":"Furihata K","journal-title":"Clin Exp Nephrol"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra021844"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.027797"},{"issue":"2","key":"cit0036","first-page":"157","volume":"48","author":"Yamada M","year":"2020","journal-title":"Jpn Pharmacol Ther"},{"issue":"1","key":"cit0037","first-page":"44","volume":"24","author":"Hosoya T","journal-title":"Clin Exp Nephrol"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1254\/fpj.20047"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2021.1918102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T05:29:25Z","timestamp":1632806965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2021.1918102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,7,24]]}},"alternative-id":["10.1080\/14656566.2021.1918102"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2021.1918102","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}